Inpatient Diabetes Mellitus (DM) Management With Continuous Glucose Monitoring Devices, a Pilot Study.

Exclusion Criteria

• •Patients that are expected to require a hospital stay ≤3 days
• •Pregnant patients
• •Subjects that have significant hyperglycemia or Diabetic Ketoacidosis (DKA) that requires treatment with intravenous insulin infusion
• •Patients receiving glucocorticosteroids in doses (equivalent) to ≥ 20 mg of hydrocortisone/day
• •Any mental condition rendering the subject incapable of understanding the objectives and potential consequences of the study
• •Patients that need hospitalization in the critical care (ICU) setting.
• •History of Diabetes Mellitus type 1 (DM1)